Clinical trial
Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema
NCT00320814 · Regeneron Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00320814 |
|---|---|
| Title | Phase 1 Study of VEGF Trap in Patients With Diabetic Macular Edema |
| Official title | An Exploratory Study of the Safety, Tolerability and Biological Effect of a Single Intravitreal Administration of VEGF Trap in Patients With Diabetic Macular Edema |
| Lead sponsor | Regeneron Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetic Macular Edema |
| Intervention type | Drug |
| Interventions | VEGF Trap-Eye |
| Enrollment | 5 |
| Start date | Apr 1, 2006 |
| Primary completion | Aug 1, 2006 |
| Completion | Aug 1, 2007 |
| First posted | May 3, 2006 |
| Last update posted | Jun 10, 2011 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: